Cargando…
Anti-M Alloimmunization: Management and Outcome at a Single Institution
Objective The objective of this study was to review the management strategies and outcomes in gravidas with anti-M alloimmunization over 15 years. Study Design Data collected from 195 pregnant patients with anti-M antibodies from July 2000 through June 2016 were reviewed retrospectively. We analyz...
Autores principales: | Stetson, Bethany, Scrape, Scott, Markham, Kara Beth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical Publishers
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5699904/ https://www.ncbi.nlm.nih.gov/pubmed/29177106 http://dx.doi.org/10.1055/s-0037-1607028 |
Ejemplares similares
-
Plasmapheresis for the Treatment of Anti-M Alloimmunization in Pregnancy
por: Maki, Yohei, et al.
Publicado: (2020) -
Hemolytic Disease of the Fetus and Newborn due to Intravenous Drug Use
por: Markham, Kara B., et al.
Publicado: (2016) -
Advances in detection of antenatal alloimmunization and its management
por: Gupte, Snehalata C.
Publicado: (2015) -
Alloimmunization in Thalassemia Patients
por: Joob, Beuy, et al.
Publicado: (2019) -
Anti-G antibody in alloimmunized pregnant women: Report of two cases
por: Makroo, Raj Nath, et al.
Publicado: (2015)